Table 2.
Differences between patients with normal left ventricular geometry and patients who had abnormal left ventricular geometry after 12 months. p Values of statistical significance (<0.05) and tendency (0.05–0.1) are shown
| First examination | Second examination | |||
|---|---|---|---|---|
| NG | Abnormal geometry | p | ||
| NG—42 patients | n | 34 | 8 (3 CR, 2 CH, 3 EH) | |
| BMI (kg/m2) | 23.3 (15.3–36.3) | 27.4 (19.7–33.5) | 0.003 | |
| BMI-SDS | 0.93 (−0.93 –5.74) | 2.36 8–0.46–5.26) | 0.006 | |
| WC (cm) | 78.5 (52–101) | 89 (71.5–102) | 0.02 | |
| WC-SDS | 0.96 (−1.72–3.71) | 1.91 (−0.66–4.94) | 0.03 | |
| WHR | 0.81 (0.68–0.97) | 0.87 (0.70–0.91) | 0.04 | |
| WHtR | 0.46 (0.37–0.56) | 0.53 (0.41–0.57) | 0.006 | |
| Uric acid (mg/dl) | 4.9 (3.0–7.7) | 6.4 (3.9–6.7) | 0.04 | |
| HDL (mg/dl) | 47 (29–66) | 37.5 (30–47) | 0.01 | |
| HbA1C (%) | 5.2 (4.7–9.8) | 5.5 (5.4–7.5) | 0.03 | |
| CR—4 patients | n | 4 | 1 (CR) | |
| CH—8 patients | n | 3 | 5 (1 CR, 2 CH, 2 EH) | |
| Insulin[120] (mU/ml) | 28.9 (25–35) | 47 (31.1–90) | 0.05 | |
| ∆ Insulin[120] (mU/ml) | −19 (−48–(−0.1)) | 24 (0–29.3) | 0.02 | |
| EH—32 patients | n | 16 | 16 (1 CR, 4 CH, 11 EH) | |
| GSH | 780.7 (694.1–821.7) | 758.5 (638.1–819.3) | 0.09 | |
Abbreviations: n, number of patients; NG, normal geometry of left ventricle; CR, concentric remodeling; CH, concentric hypertrophy; EH, eccentric hypertrophy; BMI, body mass index; WC, waist circumference; WHR, waist to hip ratio; WHtR, waist to high ratio; HbA1C, glycated hemoglobin concentration; insulin[120], insulin concentration after 120 min of oral glucose ingestion; HDL, high density lipoprotein cholesterol; GSH, reduced glutathione; SDS, standard deviation score